COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study

The Lancet Psychiatry

Fecha de publicación: 5 de agosto de 2021

Autores: Dana Tzur Bitan, PhD ,Khalaf Kridin, PhD, Prof Arnon Dov Cohen, PhD, Orly Weinstein, MD

DOI: https://doi.org/10.1016/S2215-0366(21)00256-X

Background: Individuals with schizophrenia have an increased risk of severe COVID-19 outcomes, nonetheless, no previous study has provided a year-long account of this risk, or assessed postvaccination trends in this population.


Enviar comentario